Results 211 to 220 of about 240,114 (259)

Ceftriaxone affects ferroptosis and alleviates glial cell activation in Parkinson's disease. [PDF]

Int J Mol Med
Zhi H, Wang X, Chen Y, Cai Z, Li J, Guo D.   +5 more
europepmc   +1 more source

Bilateral Lesions in Parkinson's Disease: Gaps and Controversies. [PDF]

Mov Disord
Rodriguez-Oroz MC, Martínez-Fernández R, Lipsman N, Horisawa S, Moro E.   +4 more
europepmc   +1 more source

Somatic cell reprogramming for Parkinson's disease treatment. [PDF]

Ibrain
Li X, Fang K, Wang F.
europepmc   +1 more source

Plasma Glucosylceramide Levels Are Regulated by ATP10D and Are Not Involved in Parkinson's Disease Pathogenesis. [PDF]

Ann Neurol
Somerville EN, James A, Beetz C, Schwieger R, Barrel G, Kandaswamy KK, Iurascu MI, Bauer P, Ta M, Iwaki H, Senkevich K, Yu E, Alcalay RN, Gan-Or Z.   +13 more
europepmc   +1 more source

Commentary: Three questions for the study of traumatic brain injury in animals

The Anatomical Record, EarlyView.
Gregory Hollin
wiley   +1 more source

Improvement of apathy in early Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Castrioto A, Schmitt E, Anheim M, Meoni S, Klinger H, Sourd D, Pelissier P, Lhommée E, Bichon A, Tranchant C, Moro E, Fraix V, Thobois S, Krack P.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Parkinson's disease

Neurologic Clinics, 2001
A number of changes have occurred in the management of Parkinson's disease in recent years, with the development of new therapeutic strategies based upon advances in pharmacotherapy and interventional procedures. The treatment of patients with Parkinson's disease is considered here with these advances in mind.
A E, Constantino, L S, Honig
openaire   +5 more sources

Parkinson's Disease and Parkinsonism

The American Journal of Medicine, 2019
Parkinson's disease is a progressive neurodegenerative disease characterized by tremor and bradykinesia and is a common neurologic ailment. Male sex and advancing age are independent risk factors and, as the population ages, is taking an increasing toll on productivity and medical resources.
openaire   +2 more sources

Genetics of Parkinson’s disease and parkinsonism

Expert Review of Neurotherapeutics, 2007
The past 10 years has seen a shift in our etiological concepts of Parkinson's disease, moving from a nearly exclusively environmentally mediated disease towards a complex disorder with important genetic contributors. The identification of responsible mutations in certain genes, particularly alpha-synuclein, Parkin, PINK1, DJ-1 and LRRK2, has increased ...
David J Nicholl, Michael R. Douglas, Alistair Lewthwaite   +2 more
openaire   +3 more sources